Skip to main content

LISINOPRIL

NDC 43547-351 · Solco healthcare U.S., LLC

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength2.5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

43547-351-03 — 30 TABLET in 1 BOTTLE (43547-351-03)

43547-351-10 — 100 TABLET in 1 BOTTLE (43547-351-10)

43547-351-50 — 500 TABLET in 1 BOTTLE (43547-351-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43063-811 — Lisinopril, 43063-812 — Lisinopril, 43063-813 — Lisinopril, 43063-814 — Lisinopril, 43063-815 — Lisinopril, 43353-009 — lisinopril, 43353-270 — lisinopril, 43353-271 — lisinopril, 43353-298 — lisinopril, 43353-301 — lisinopril, 43547-352 — Lisinopril, 43547-353 — Lisinopril, 43547-354 — Lisinopril, 43547-355 — Lisinopril, 43547-356 — Lisinopril, 43547-414 — Lisinopril, 43547-415 — Lisinopril, 43547-416 — Lisinopril, 43547-417 — Lisinopril, 43547-418 — Lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels